Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Idera Pharmaceuticals Inc announces closing of public offering of common stock


Monday, 10 Feb 2014 04:15pm EST 

Idera Pharmaceuticals Inc:Says the closing of its previously announced underwritten public offering of 7,867,438 shares of common stock at an offering price of $4.00 per share, and pre-funded warrants to purchase up to an aggregate of 2,158,750 shares of common stock at an offering price of $3.99 per pre-funded warrant.Says the gross proceeds to Idera from this offering are expected to be about $40.0 mln, before deducting the underwriting discounts and commissions and other estimated offering expenses.Says Piper Jaffray & Co. and Cowen and Company, LLC acted as joint bookrunning managers for the offering. 

Company Quote

2.46
-0.08 -3.15%
19 Sep 2014